CD226 and neoplasm: Unfortunately, CD226 expression is down-regulated on CD8+ TILs in mouse and human tumors (38, 54, 71, 72), especially on CD8+PD-1hi exhausted dysfunctional CD8+ TILs (31) which have been shown to contain the majority of tumor-reactive cells (57, 73).